Cargando…

Coevolution of COVID-19 research and China’s policies

BACKGROUND: In the era of evidence-based policy-making (EBPM), scientific outputs and public policy should engage with each other in a more interactive and coherent way. Notably, this is becoming increasingly critical in preparing for public health emergencies. METHODS: To explore the coevolution dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xi, Tang, Li, Zhou, Maotian, Wang, Guoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419657/
https://www.ncbi.nlm.nih.gov/pubmed/34488797
http://dx.doi.org/10.1186/s12961-021-00770-6
_version_ 1783748799614681088
author Cheng, Xi
Tang, Li
Zhou, Maotian
Wang, Guoyan
author_facet Cheng, Xi
Tang, Li
Zhou, Maotian
Wang, Guoyan
author_sort Cheng, Xi
collection PubMed
description BACKGROUND: In the era of evidence-based policy-making (EBPM), scientific outputs and public policy should engage with each other in a more interactive and coherent way. Notably, this is becoming increasingly critical in preparing for public health emergencies. METHODS: To explore the coevolution dynamics between science and policy (SAP), this study explored the changes in, and development of, COVID-19 research in the early period of the COVID-19 outbreak in China, from 30 December 2019 to 26 June 2020. In this study, VOSviewer was adopted to calculate the link strength of items extracted from scientific publications, and machine learning clustering analysis of scientific publications was carried out to explore dynamic trends in scientific research. Trends in relevant policies that corresponded to changing trends in scientific research were then traced. RESULTS: The study observes a salient change in research content as follows: an earlier focus on “children and pregnant patients”, “common symptoms”, “nucleic acid test”, and “non-Chinese medicine” was gradually replaced with a focus on “aged patients”, “pregnant patients”, “severe symptoms and asymptomatic infection”, “antibody assay”, and “Chinese medicine”. “Mental health” is persistent throughout China’s COVID-19 research. Further, our research reveals a correlation between the evolution of COVID-19 policies and the dynamic development of COVID-19 research. The average issuance time of relevant COVID-19 policies in China is 8.36 days after the launching of related research. CONCLUSIONS: In the early stage of the outbreak in China, the formulation of research-driven-COVID-19 policies and related scientific research followed a similar dynamic trend, which is clearly a manifestation of a coevolution model (CEM). The results of this study apply more broadly to the formulation of policies during public health emergencies, and provide the foundation for future EBPM research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12961-021-00770-6.
format Online
Article
Text
id pubmed-8419657
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84196572021-09-07 Coevolution of COVID-19 research and China’s policies Cheng, Xi Tang, Li Zhou, Maotian Wang, Guoyan Health Res Policy Syst Research BACKGROUND: In the era of evidence-based policy-making (EBPM), scientific outputs and public policy should engage with each other in a more interactive and coherent way. Notably, this is becoming increasingly critical in preparing for public health emergencies. METHODS: To explore the coevolution dynamics between science and policy (SAP), this study explored the changes in, and development of, COVID-19 research in the early period of the COVID-19 outbreak in China, from 30 December 2019 to 26 June 2020. In this study, VOSviewer was adopted to calculate the link strength of items extracted from scientific publications, and machine learning clustering analysis of scientific publications was carried out to explore dynamic trends in scientific research. Trends in relevant policies that corresponded to changing trends in scientific research were then traced. RESULTS: The study observes a salient change in research content as follows: an earlier focus on “children and pregnant patients”, “common symptoms”, “nucleic acid test”, and “non-Chinese medicine” was gradually replaced with a focus on “aged patients”, “pregnant patients”, “severe symptoms and asymptomatic infection”, “antibody assay”, and “Chinese medicine”. “Mental health” is persistent throughout China’s COVID-19 research. Further, our research reveals a correlation between the evolution of COVID-19 policies and the dynamic development of COVID-19 research. The average issuance time of relevant COVID-19 policies in China is 8.36 days after the launching of related research. CONCLUSIONS: In the early stage of the outbreak in China, the formulation of research-driven-COVID-19 policies and related scientific research followed a similar dynamic trend, which is clearly a manifestation of a coevolution model (CEM). The results of this study apply more broadly to the formulation of policies during public health emergencies, and provide the foundation for future EBPM research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12961-021-00770-6. BioMed Central 2021-09-06 /pmc/articles/PMC8419657/ /pubmed/34488797 http://dx.doi.org/10.1186/s12961-021-00770-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cheng, Xi
Tang, Li
Zhou, Maotian
Wang, Guoyan
Coevolution of COVID-19 research and China’s policies
title Coevolution of COVID-19 research and China’s policies
title_full Coevolution of COVID-19 research and China’s policies
title_fullStr Coevolution of COVID-19 research and China’s policies
title_full_unstemmed Coevolution of COVID-19 research and China’s policies
title_short Coevolution of COVID-19 research and China’s policies
title_sort coevolution of covid-19 research and china’s policies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419657/
https://www.ncbi.nlm.nih.gov/pubmed/34488797
http://dx.doi.org/10.1186/s12961-021-00770-6
work_keys_str_mv AT chengxi coevolutionofcovid19researchandchinaspolicies
AT tangli coevolutionofcovid19researchandchinaspolicies
AT zhoumaotian coevolutionofcovid19researchandchinaspolicies
AT wangguoyan coevolutionofcovid19researchandchinaspolicies